ethypharm holdings uk ltd
ethypharm holdings uk ltd Company Information
Company Number
09116775
Website
www.ethypharm.co.ukRegistered Address
2nd floor regis house, 45 king william street, london, EC4R 9AN
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Telephone
01628551900
Next Accounts Due
October 2024
Group Structure
View All
Shareholders
ethypharm sa 100%
ethypharm holdings uk ltd Estimated Valuation
Pomanda estimates the enterprise value of ETHYPHARM HOLDINGS UK LTD at £69.3k based on a Turnover of £59k and 1.17x industry multiple (adjusted for size and gross margin).
ethypharm holdings uk ltd Estimated Valuation
Pomanda estimates the enterprise value of ETHYPHARM HOLDINGS UK LTD at £141.9m based on an EBITDA of £32.3m and a 4.39x industry multiple (adjusted for size and gross margin).
ethypharm holdings uk ltd Estimated Valuation
Pomanda estimates the enterprise value of ETHYPHARM HOLDINGS UK LTD at £33.2m based on Net Assets of £18.1m and 1.84x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ethypharm Holdings Uk Ltd Overview
Ethypharm Holdings Uk Ltd is a dissolved company that was located in london, EC4R 9AN with a Companies House number of 09116775. It operated in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in July 2014, it's largest shareholder was ethypharm sa with a 100% stake. The last turnover for Ethypharm Holdings Uk Ltd was estimated at £59k.
Upgrade for unlimited company reports & a free credit check
Ethypharm Holdings Uk Ltd Health Check
Pomanda's financial health check has awarded Ethypharm Holdings Uk Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £59k, make it smaller than the average company (£15.2m)
£59k - Ethypharm Holdings Uk Ltd
£15.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -63%, show it is growing at a slower rate (4.2%)
-63% - Ethypharm Holdings Uk Ltd
4.2% - Industry AVG
Production
with a gross margin of 34.4%, this company has a comparable cost of product (34.4%)
34.4% - Ethypharm Holdings Uk Ltd
34.4% - Industry AVG
Profitability
an operating margin of 54728.8% make it more profitable than the average company (4%)
54728.8% - Ethypharm Holdings Uk Ltd
4% - Industry AVG
Employees
with 1 employees, this is below the industry average (110)
1 - Ethypharm Holdings Uk Ltd
110 - Industry AVG
Pay Structure
on an average salary of £154k, the company has a higher pay structure (£38.5k)
£154k - Ethypharm Holdings Uk Ltd
£38.5k - Industry AVG
Efficiency
resulting in sales per employee of £59k, this is less efficient (£150.2k)
£59k - Ethypharm Holdings Uk Ltd
£150.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Ethypharm Holdings Uk Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 339 days, this is slower than average (47 days)
339 days - Ethypharm Holdings Uk Ltd
47 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Ethypharm Holdings Uk Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (15 weeks)
0 weeks - Ethypharm Holdings Uk Ltd
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.5%, this is a similar level of debt than the average (72.2%)
75.5% - Ethypharm Holdings Uk Ltd
72.2% - Industry AVG
ETHYPHARM HOLDINGS UK LTD financials
Ethypharm Holdings Uk Ltd's latest turnover from December 2020 is £59 thousand and the company has net assets of £18.1 million. According to their latest financial statements, Ethypharm Holdings Uk Ltd has 1 employee and maintains cash reserves of £588 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|
| Turnover | 59,000 | 72,000 | 294,000 | 1,141,000 | 1,014,653 | 0 |
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | 32,290,000 | -38,711,000 | -705,000 | -1,344,000 | -6,189,760 | -415,270 |
| Interest Payable | 2,617,000 | 2,602,000 | 2,631,000 | 2,472,000 | 2,556,369 | 546,774 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 29,892,000 | -32,702,000 | -3,336,000 | -3,815,000 | -4,146,129 | -962,044 |
| Tax | 0 | 6,000 | 0 | 724,000 | 1,622,716 | 192,596 |
| Profit After Tax | 29,892,000 | -32,696,000 | -3,336,000 | -3,091,000 | -2,523,413 | -769,448 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 29,892,000 | -32,696,000 | -3,336,000 | -3,091,000 | -2,523,413 | -769,448 |
| Employee Costs | 154,000 | 125,000 | 85,000 | 412,000 | 347,650 | 96,930 |
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA* | 32,335,000 | -38,711,000 | -705,000 | -1,344,000 | -6,189,760 | -415,270 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 285,000 | 330,000 | 450,000 | 450,000 | 0 | 0 |
| Investments & Other | 0 | 36,372,000 | 74,240,000 | 74,240,000 | 74,914,887 | 74,120,710 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 285,000 | 36,702,000 | 74,690,000 | 74,690,000 | 74,914,887 | 74,120,710 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 40,000 | 0 | 0 |
| Group Debtors | 3,396,000 | 370,000 | 4,750,000 | 1,860,000 | 1,009,398 | 192,596 |
| Misc Debtors | 117,000 | 0 | 1,000 | 25,000 | 0 | 79,489 |
| Cash | 588,000 | 4,380,000 | 34,000 | 230,000 | 359,203 | 0 |
| misc current assets | 69,602,000 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 73,703,000 | 4,750,000 | 4,785,000 | 2,155,000 | 1,368,601 | 272,085 |
| total assets | 73,988,000 | 41,452,000 | 79,475,000 | 76,845,000 | 76,283,488 | 74,392,795 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 35,393,000 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 36,000 | 0 | 0 | 6,916,000 | 12,805 | 29,808 |
| Group/Directors Accounts | 20,456,000 | 7,579,000 | 12,666,000 | 0 | 3,034,077 | 4,837,297 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 56,000 | 215,000 | 0 | 1,363,096 | 86,953 |
| total current liabilities | 55,885,000 | 7,635,000 | 12,881,000 | 6,916,000 | 4,409,978 | 4,954,058 |
| loans | 0 | 45,606,000 | 45,687,000 | 45,686,000 | 44,539,425 | 27,306,239 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 12,275,000 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 45,606,000 | 45,687,000 | 45,686,000 | 44,539,425 | 39,581,239 |
| total liabilities | 55,885,000 | 53,241,000 | 58,568,000 | 52,602,000 | 48,949,403 | 44,535,297 |
| net assets | 18,103,000 | -11,789,000 | 20,907,000 | 24,243,000 | 27,334,085 | 29,857,498 |
| total shareholders funds | 18,103,000 | -11,789,000 | 20,907,000 | 24,243,000 | 27,334,085 | 29,857,498 |
| Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | 32,290,000 | -38,711,000 | -705,000 | -1,344,000 | -6,189,760 | -415,270 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 45,000 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 6,000 | 0 | 724,000 | 1,622,716 | 192,596 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 3,143,000 | -4,381,000 | 2,826,000 | 915,602 | 737,313 | 272,085 |
| Creditors | 36,000 | 0 | -6,916,000 | 6,903,195 | -17,003 | 29,808 |
| Accruals and Deferred Income | -56,000 | -159,000 | 215,000 | -1,363,096 | 1,276,143 | 86,953 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 29,172,000 | -34,483,000 | -10,232,000 | 4,004,497 | -4,045,217 | -377,998 |
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | -36,372,000 | -37,868,000 | 0 | -674,887 | 794,177 | 74,120,710 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 35,393,000 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 12,877,000 | -5,087,000 | 12,666,000 | -3,034,077 | -1,803,220 | 4,837,297 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -45,606,000 | -81,000 | 1,000 | 1,146,575 | 17,233,186 | 27,306,239 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | -12,275,000 | 12,275,000 |
| share issue | ||||||
| interest | -2,617,000 | -2,602,000 | -2,631,000 | -2,472,000 | -2,556,369 | -546,774 |
| cash flow from financing | 47,000 | -7,770,000 | 10,036,000 | -4,359,587 | 598,597 | 74,498,708 |
| cash and cash equivalents | ||||||
| cash | -3,792,000 | 4,346,000 | -196,000 | -129,203 | 359,203 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -3,792,000 | 4,346,000 | -196,000 | -129,203 | 359,203 | 0 |
ethypharm holdings uk ltd Credit Report and Business Information
Ethypharm Holdings Uk Ltd Competitor Analysis
Perform a competitor analysis for ethypharm holdings uk ltd by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other undefined companies, companies in EC4R area or any other competitors across 12 key performance metrics.
ethypharm holdings uk ltd Ownership
ETHYPHARM HOLDINGS UK LTD group structure
Ethypharm Holdings Uk Ltd has 2 subsidiary companies.
Ultimate parent company
FINANCIERE VERDI III
#0094521
ETHYPHARM SA
#0094860
2 parents
ETHYPHARM HOLDINGS UK LTD
09116775
2 subsidiaries
ethypharm holdings uk ltd directors
Ethypharm Holdings Uk Ltd currently has 2 directors. The longest serving directors include Ms Roseline Joannesse (Mar 2018) and Mr Emmanuel Schmidt (Jul 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Roseline Joannesse | France | 65 years | Mar 2018 | - | Director |
| Mr Emmanuel Schmidt | France | 55 years | Jul 2019 | - | Director |
P&L
December 2020turnover
59k
-18%
operating profit
32.3m
-183%
gross margin
34.5%
-0.63%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2020net assets
18.1m
-2.54%
total assets
74m
+0.78%
cash
588k
-0.87%
net assets
Total assets minus all liabilities
ethypharm holdings uk ltd company details
company number
09116775
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
July 2014
age
10
incorporated
UK
accounts
Full Accounts
ultimate parent company
previous names
aida iv ltd (September 2015)
last accounts submitted
December 2020
address
2nd floor regis house, 45 king william street, london, EC4R 9AN
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
ethypharm holdings uk ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to ethypharm holdings uk ltd. Currently there are 0 open charges and 4 have been satisfied in the past.
ethypharm holdings uk ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
